Lipids – BJC TV https://tv.bjcardio.co.uk Short video updates for cardiologists Thu, 19 Mar 2026 14:43:48 +0000 en-GB hourly 1 https://wordpress.org/?v=6.9.4 https://tv.bjcardio.co.uk/wp-content/uploads/2023/06/cropped-favicon-32x32.png Lipids – BJC TV https://tv.bjcardio.co.uk 32 32 Masterclass: Lipoprotein(a) – a suitable case for treatment? https://tv.bjcardio.co.uk/featured-videos/lipoproteina-a-suitable-case-for-treatment/ https://tv.bjcardio.co.uk/featured-videos/lipoproteina-a-suitable-case-for-treatment/#comments Tue, 10 Dec 2024 09:00:00 +0000 https://tv.bjcardio.co.uk/?p=9727 Learning objectives
  • Why, how and in whom Lp(a) should be measured
  • Management of people with high Lp(a) levels
  • The role of Lp(a) in atherosclerotic coronary artery disease
  • Future prospects for the treatment of people with high Lp(a) levels
Speakers

Dr Dermot Neely Retired Lipidologist, HEART UK Trustee
Dr Jai Cegla Consultant in Chemical Pathology and Metabolic Medicine, Imperial College Healthcare NHS Trust

Learning module instructions

This BJC TV Learning module has a recommended award of 1 CPD credit for completion (1 hour of learning).
Completion requires a score of at least 80%. If less time is spent learning, then you should claim a reduced credit value.
After you have successfully completed the test you will be able to download your certificate.


Click here to view a podcast summary of the video discussion.

References:

  1. Cegla J et al. Atherosclerosis 2019;291:62–70
  2. Cegla J et al. Ann Clin Biochem 2021;58:16–21
  3. Lp(a) Clinical Guidance (2023). Lp(a) risk calculator. Available at: https://www.lpaclinicalguidance.com/ (accessed December 2024)
  4. National Clinical Guideline for stroke for the United Kingdom and Ireland (2023 edition). Available at: https://www.strokeguideline.org/app/uploads/2023/04/National-Clinical-Guideline-for-Stroke-2023.pdf (accessed December 2024)

]]> https://tv.bjcardio.co.uk/featured-videos/lipoproteina-a-suitable-case-for-treatment/feed/ 1 Masterclass: Treating dyslipidaemia – special populations https://tv.bjcardio.co.uk/featured-videos/masterclass-treating-dyslipidaemia-special-populations/ Thu, 08 Aug 2024 15:54:46 +0000 https://tv.bjcardio.co.uk/?p=9454

Speakers

Alison Pottle Consultant Nurse in Cardiology, Harefield Hospital, UK
Jai Cegla Consultant in Chemical Pathology and Metabolic Medicine, Imperial College Healthcare NHS Trust, UK 

Learning objectives

    • To discuss the available tools and potential barriers to screening for FH

    • To provide an overview of the recent advances in treatment for dyslipidaemia

    • To discuss the role of lipid apheresis in treating people with homozygous FH

    • To outline key discussion points to raise with people with dyslipidaemia

    Learning module instructions

    This BJC TV Learning module has a recommended award of 1 CPD credit for completion (1 hour of learning).
    Completion requires a score of at least 80%. If less time is spent learning, then you should claim a reduced credit value.
    After you have successfully completed the test you will be able to download your certificate.

    References

    1. NICE (2019) Familial hypercholesterolaemia: identification and management [CG71]. Available at: https://www.nice.org.uk/guidance/cg71 (accessed August 2024)

    2. Morrell J. Br J Cardiol 2008;15:79–81.

    3. Public Health England (2018) Familial Hypercholesterolaemia – Implementing a systems approach to detection and management. Available at: https://assets.publishing.service.gov.uk/media/5b646bbced915d37793abcda/familial_hypercholesterolaemia_implementation_guide.pdf (accessed August 2024).

    4. Benn M et al. Eur Heart J. 2016;37:1384–1394.

    5. Mach F et al. Eur Heart J. 2020;41:111–188.

    ]]>         Masterclass: Hypertriglyceridaemia: from fish oils to fibrates https://tv.bjcardio.co.uk/featured-videos/masterclass-hypertriglyceridaemia-from-fish-oils-to-fibrates/ Fri, 24 May 2024 10:16:37 +0000 https://tv.bjcardio.co.uk/?p=8864
    Speakers

    Dr Derek Connolly Consultant Cardiologist  at Birmingham City Hospital, Birmingham
    Dr Dermot Neely Retired Lipidologist, HEART UK Trustee

    Learning objectives

    • Triglycerides as a target for treatment
    • How treatment can improve outcomes
    • The role of highly-purified omega-3 fatty acid (icosapent ethyl) to treat hypertriglyceridaemia
    • Early versus later omega-3 fatty acid studies
    • REDUCE-IT – randomised, double-blind, placebo-controlled trial looking at cardiovascular risk reduction with icosapent ethyl for hypertriglyceridaemia

    Learning module instructions

    This BJC TV Learning module has a recommended award of 1 CPD credit for completion (1 hour of learning). Completion requires a score of at least 80%. If less time is spent learning, then you should claim a reduced credit value. After you have successfully completed the test you will be able to download your certificate.

    References
    1. NIH. High blood triglycerides. 2023. Available at: https://www.nhlbi.nih.gov/health/high-blood-triglycerides#:~:text=Triglycerides%20are%20a%20type%20of,and%20other%20fats%20you%20eat  (accessed March 2024)
    2. NICE. Icosapent ethyl with statin therapy for reducing the risk of cardiovascular events in people with raised triglycerides [TA805] 2022. Available at: https://www.nice.org.uk/guidance/ta805. (accessed March 2024)
    3. Padda IS et al. StatPearls [Internet]. Available at: https://www.ncbi.nlm.nih.gov/books/NBK592399/ (accessed March 2024)
    4. Heart UK. Type 3 hyperlipidaemia. Available at: https://www.heartuk.org.uk/genetic-conditions/type-3-hyperlipidaemia (accessed March 2024)
    5. Heart UK. Triglycerides. 2024. Available at: https://www.heartuk.org.uk/cholesterol/triglycerides (accessed March 2024)
    6. Bhatt DL et al. N Engl J Med 2019;380:11–22
    7. Benuck I et al. Endotext [Internet]. Available at: https://www.ncbi.nlm.nih.gov/books/NBK395574/ (accessed March 2024)
    ]]>         Masterclass: Looking at lipids – dyslipidemia in CVD prevention https://tv.bjcardio.co.uk/featured-videos/masterclass-looking-at-lipids-dyslipidemia-in-cvd-prevention/ Tue, 30 Apr 2024 13:58:23 +0000 https://tv.bjcardio.co.uk/?p=8742
    Speakers

    Professor Terry McCormack Professor of Primary Care Cardiovascular Medicine, Hull York Medical School
    Dr Peter Green GP, High Parks Medical Practice, University of Kent

    Learning objectives

    • Understand the national guidelines for lipid management for primary and secondary prevention of CVD
    • Understand the lipid targets for prevention of CVD
    • Update knowledge on assessing cholesterol levels and understand why guidelines now include measurements for non-high-density lipoprotein cholesterol (non-HDL-C)
    • Understand the national guidelines for CVD risk assessment and follow up
    • Recognise the importance and use of smart open-access data tools CVDPREVENT and CVDACTION

    Learning module instructions

    This BJC TV Learning module has a recommended award of 1 CPD credit for completion (1 hour of learning). Completion requires a score of at least 80%. If less time is spent learning, then you should claim a reduced credit value. After you have successfully completed the test you will be able to download your certificate.

    References
    1. NHS England. Summary of national guidance for lipid management for primary and secondary prevention of CVD. 2022. Available from: https://www.england.nhs.uk/aac/wp-content/uploads/sites/50/2020/04/lipid-management-pathway-v6.pdf (accessed April 2024)
    2. Cardiovascular disease: risk assessment and reduction, including lipid modification [NG238]. 2023. Available from: https://www.nice.org.uk/guidance/ng238/resources/cardiovascular-disease-risk-assessment-and-reduction-including-lipid-modification-pdf-66143902851781 (accessed April 2024)
    3. Reynolds TM et al. Vasc Health Risk Manag 2021;17:227–37
    4. Guo L-L et al. Front Cardiovasc Med 2021;8:649181
    5. Liu M-M et al. Ann Transl Med 2021;9:386
    6. UCLPartners Health Innovation. CVDACTION: Transforming the prevention of cardiovascular disease. Available from: https://uclpartners.com/our-priorities/cardiovascular/cvdaction-transforming-the-prevention-of-cardiovascular-disease/ (accessed April 2024)
    7. Ma H, Shieh K-J. Am J Sci 2006;2:46–50
    8. Nelson RH. Prim Care 2013;40:195–211
    9. Taskinen MR, Borén J. Atherosclerosis 2015;239:483–95
    10. Chiesa ST et al. Eur Heart J 2019;40:3559–66
    11. Reiss AB et al. Am J Kidney Dis 2015;66:1071–82
    ]]>         Masterclass: Lipids – Non-statin approaches to treatment https://tv.bjcardio.co.uk/masterclass/masterclass-lipids-non-statin-approaches-to-treatment/ Tue, 05 Mar 2024 10:24:19 +0000 https://tv.bjcardio.co.uk/?p=8490
    Speakers

    Dr Rani Khatib Consultant Pharmacist in Cardiology & Cardiovascular Research, Leeds Teaching Hospitals NHS Trust
    Dr Dermot Neely Specialist Adviser on lipids to Academic Health Science Network – North-East and North Cumbria

    Learning objectives

    • Understand the national lipid management pathway, and primary and secondary prevention of cardiovascular disease

    • Understand when non-statin therapeutic approaches may be indicated in clinical practice

    • Identify the patient groups who may benefit from non-statin lipid-lowering therapeutic options

    Learning module instructions

    This BJC TV Learning module has a recommended award of 1 CPD credit for completion (1 hour of learning). Completion requires a score of at least 80%. If less time is spent learning, then you should claim a reduced credit value. After you have successfully completed the test you will be able to download your certificate.

    References
    1. NHS England. Improving lipid management to reduce cardiovascular disease and save lives. 2023. Available at: https://www.england.nhs.uk/long-read/improving-lipid-management-to-reduce-cardiovascular-disease-and-save-lives/ (accessed February 2024)
    2. NICE. CKS. Lipid modification – CVD prevention: Statins. 2023. Available at: https://cks.nice.org.uk/topics/lipid-modification-cvd-prevention/prescribing-information/statins/ (accessed February 2024)
    3. NHS England. Summary of National Guidance for Lipid Management for Primary and Secondary Prevention of CVD. Available at: https://www.england.nhs.uk/aac/wp-content/uploads/sites/50/2020/04/lipid-management-pathway-v6.pdf (accessed February 2024)
    4. NICE. Cardiovascular disease: risk assessment and reduction, including lipid modification [NG238]. December 2023. Available at: https://www.nice.org.uk/guidance/ng238/chapter/Recommendations (accessed February 2024)
    ]]>